A Study of a Personalized Neoantigen Cancer Vaccine

Condition:   Solid Tumor Interventions:   Biological: GRT-C901;   Biological: GRT-R902;   Biological: nivolumab;   Biological: ipilimumab Sponsors:   Gritstone Oncology, Inc.;   Bristol-Myers Squibb Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials